Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors
An open-label dose escalation study of patients with solid tumors treated with STA-9090 (ganetespib)
Solid Tumors
DRUG: STA-9090
The safety and tolerability of STA-9090 (ganetespib) in cancer patients via assessment of dose limiting toxicities, Cycle 1
An open-label dose escalation study of patients with solid tumors treated with STA-9090 (ganetespib)